Latest filing published 20 Jul 2026 for NANOBIOTIX, €227k. Read the official filing
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Gary Phillips (board member) discloses dealings in Nanobiotix to AMF. The record holds 4 filings, for trades running from 13 June 2025 to 16 July 2026.
On the market, this insider has only ever bought: 4 purchases, €335k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2026, the count stands at 3 purchases and no sales.
In size, the median ticket on the buying side is €42k. On 1 out of 4 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +105.7%. Past outcomes like these are no guarantee of what comes next.
Most recently, on 20 July 2026, the filings show an open-market purchase worth €227k in Nanobiotix. Filings reach the AMF feed a median of 3 days after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by AMF and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations